JPIAMR’s Post

Our CEO, Jeff Nesbitt, MBA, ICD.D, senior director of partnerships and external relations, Betsy Nejat, CAE, and Vice Chair of the CHIMA Board of Directors, Jen Bennett, joined AHIMA and Andrew Tomlinson yesterday for a wonderful panel discussion titled, Beyond the Border: How Health IT is Shaping Global Health #AdvocacySummit24

Interesting workshop at the International Consortium for Health Outcomes Measurement (ICHOM) conference about how to include payment models in VBHC implementation, led by Fares A. Saade (CAPADEV LLP). We all agreed that we need payments models, but must consider both intrinsic and extrinsic incentives (e.g. accreditation system) and not only for those conditions with high economic burden but also for those where outcome variation is a problem. Importance of PROMs as early signs, even in agreements based on CROMs.

📰 #EUCAIM has been featured in the new issue of HealthManagement.org 🙌 Read this issue here: 🔗 https://lnkd.in/eE9JSZFQ Direct link to EUCAIM's cover story 👉 https://lnkd.in/eWbjt7tk

Talk about stacking the bench!

Learning from the best

Join us for the first seminar in our series with Olaniyi Olaoluwa Team Lead of HIM MEDIA NG , on "Change Management and Innovative Adoption in Health Information Management Practice." Date: December 1st, 4:00 PM Moderator: Samuel OGUNDIRAN Platform: Google Meet Link: https://lnkd.in/d42nWGR5 Stay tuned for more updates and follow our social media for future initiatives! #ShapingTheFutureOfHealthInformationManagementPracticeInNigeria

Many thanks to ATACH, IFPMA, The Sustainable Markets Initiative for the opportunity to share some of Unitaid's insights and lessons in relation to greening supply chains. And thanks to my co-panelists and the audience for a lively discussion. My key takeaways: 👉 Greening health supply chains is an absolute priority: according to SMI, they represent 60% of the health sector footprint; in our recent Unitaid study "from milligrams to megatons" we have shown that the supply chain of a single medicine can be as high as the annual emissions of the city of Geneva. 👉 Carbon emissions cannot be managed in isolation from other environmental issues; health supply chains are also responsible for significant environmental impacts (eg, pollution, plastic waste); they are also exposed to significant climate risks (eg, floods, access to water, extreme heat). All three aspects will be much better managed if taken together. 👉 It is great to see increasing leadership from the private sector on this issue; some companies have demonstrated that they take sustainability very seriously and have pioneered impactful initiatives; many others need to join them. 👉 Regional manufacturing should be seen as an opportunity for sustainability: to improve resilience of supply chains, increase proximity to markets, and leapfrog to high sustainability standards from the start. 👉 We are facing a deep transformation of an entire sector: private sector alone cannot do it; we'll need to evolve policies, regulations, procurement practices; we'll need to foster innovation (both public and private); and we need to start with the communities and the patients. Above all, we'll need strong collaboration and partnership. 👉 #ATACH is well placed to be a strong catalyst of this transformation. Unitaid looks forward to working with all partners to advance this agenda. Niels Lund Ann-Lise Mikolajczak Lasha Goguadze Jan-Willem Scheijgrond Chris Gormley Zuleika Henderson Diarmid Campbell-Lendrum Elena Villalobos Prats Julien Pouille Matthew Lindley Robert Matiru Kenny Onasanya MCIPS, SCMP, RegPracProc Ademola Osigbesan

Strengthening health information systems (HIS) is among our key priorities for WHO/Europe as we continue advancing data and #DigitalHealth in Europe. Over the next years, we will conduct a series of HIS assessments across the region, helping countries identify strengths and weaknesses, and accelerate their #DigitalTransformation in health to improve their evidence base for decision-making. To prepare for this important work, we welcomed 12 health information experts to UN City Copenhagen for a special training session, co-funded by the European Union. The course equipped participants with the skills to apply WHO/Europe's HIS assessment methodology, ensuring each country's mission is impactful and well-supported. We are proud to partner with the EU Health and Food Safety to empower countries to leverage data for better health. Discover more about WHO/Europe’s work on health information systems: https://bit.ly/40rZOzx Marieke Verschuuren Karapet Davtyan

📊 ELTIF: “The revised European long-term investment fund regulation is meant to boost investment into the real economy and increase access by retail investors.” Dr. Stefan Staedter discusses the changes in the new regime in the article for Delano. 📰 Read the full article here >  https://lnkd.in/ePHnUc-J 💡 Learn more about our: - Investment Management practice > https://lnkd.in/e7t-TqM - ELTIF expertise > https://lnkd.in/eHfCFvh2 #Luxembourg #law #ELTIFs #investments #finance #investmentmanagement #Investmentfunds #funds #fundsmanagement

𝗖𝗧𝗜𝗦 𝗧𝗿𝗮𝗻𝘀𝗶𝘁𝗶𝗼𝗻 – 𝗡𝗼𝘄 𝗼𝗿 𝗡𝗲𝘃𝗲𝗿! Still wondering: Do I really need to transition my trial? Here are a few scenarios that might help you decide and take the right action: 𝑃𝑟𝑎𝑐𝑡𝑖𝑐𝑎𝑙 𝑒𝑥𝑎𝑚𝑝𝑙𝑒𝑠: ✅ There are delays in recruitment, but I hope recruitment will finish by the end of 2024. 𝗬𝗲𝘀, 𝘁𝗿𝗮𝗻𝘀𝗶𝘁𝗶𝗼𝗻. If patient visits are ongoing after 30 Jan 2025, you will need to transition. ❌ My trial will be fully completed in Europe by August 2024, and will continue only in the US in 2025. 𝗡𝗼, 𝗱𝗼 𝗻𝗼𝘁 𝘁𝗿𝗮𝗻𝘀𝗶𝘁𝗶𝗼𝗻. You’re safe if your trial wraps up in Europe before January 2025. ❌ Recruitment is done, and Last Patient Last Visit (LPLV) is scheduled for December 2024. 𝗡𝗼, 𝗱𝗼 𝗻𝗼𝘁 𝘁𝗿𝗮𝗻𝘀𝗶𝘁𝗶𝗼𝗻. If your trial’s European phase finishes on time, no transition is needed. 🔑 𝗞𝗲𝘆 𝘁𝗮𝗸𝗲𝗮𝘄𝗮𝘆: If there’s any uncertainty about your timelines, it’s safer to transition now and avoid future complications. 🎥 In this clip from my recent live event, Sam Bryant shares his expertise on this hot topics ! Want the full breakdown? 𝗖𝗵𝗲𝗰𝗸 𝗼𝘂𝘁 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 𝗼𝗻 𝗺𝘆 𝗽𝗿𝗼𝗳𝗶𝗹𝗲, and feel free to ask questions in the comments or reach out directly!